Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0V7HD
|
||||
Former ID |
DIB007860
|
||||
Drug Name |
BN-50726
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Nerve injury [ICD10:T14.4] | Terminated | [1] | ||
Company |
Ipsen
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C34H48ClN5O2S2
|
||||
Canonical SMILES |
c12c(C(=NCc3n1c(nn3)C)c1c(Cl)cccc1)c1c(s2)CN(S(=O)(=O)C<br />CCCCCCCCCCCCCCC)CC1
|
||||
CAS Number |
CAS 127279-06-5
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Platelet-activating factor receptor | Target Info | Antagonist | [2] | |
KEGG Pathway | Calcium signaling pathway | ||||
Neuroactive ligand-receptor interaction | |||||
Staphylococcus aureus infection | |||||
NetPath Pathway | IL5 Signaling Pathway | ||||
Leptin Signaling Pathway | |||||
Reactome | Class A/1 (Rhodopsin-like receptors) | ||||
G alpha (q) signalling events | |||||
Interferon gamma signaling | |||||
WikiPathways | GPCRs, Class A Rhodopsin-like | ||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
Small Ligand GPCRs | |||||
Interferon gamma signaling | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001821) | ||||
REF 2 | Effects of the PAF antagonists BN50726 and BN50739 on arrhythmogenesis and extent of necrosis during myocardial ischaemia/reperfusion in rabbits. Br J Pharmacol. 1992 Nov;107(3):705-9. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.